Pharma Reviews: FDC ban controversy: Appeals expected, as pharma industry gets a breather

Data from the AIOCD (All India Organisation of Chemists and Druggists) pegged the FDC ban impact at about 3 percent of the Indian pharmaceutical ...
Read more: FDC ban controversy: Appeals expected, as pharma industry gets a breather